Adma Biologics Stock Technical Analysis
| ADMA Stock | USD 16.28 0.09 0.55% |
As of the 11th of February 2026, ADMA Biologics shows the Risk Adjusted Performance of 0.0426, semi deviation of 2.74, and Mean Deviation of 2.22. ADMA Biologics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
ADMA Biologics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ADMA, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ADMAADMA Biologics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.ADMA Biologics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 25.67 | Strong Buy | 3 | Odds |
Most ADMA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ADMA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ADMA Biologics, talking to its executives and customers, or listening to ADMA conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ADMA Biologics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 0.85 | Revenue Per Share | Quarterly Revenue Growth 0.12 | Return On Assets | Return On Equity |
ADMA Biologics's market price often diverges from its book value, the accounting figure shown on ADMA's balance sheet. Smart investors calculate ADMA Biologics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ADMA Biologics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that ADMA Biologics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ADMA Biologics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ADMA Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ADMA Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ADMA Biologics.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in ADMA Biologics on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding ADMA Biologics or generate 0.0% return on investment in ADMA Biologics over 90 days. ADMA Biologics is related to or competes with ACADIA Pharmaceuticals, Praxis Precision, Belite Bio, Ligand Pharmaceuticals, Soleno Therapeutics, Mirum Pharmaceuticals, and Dyne Therapeutics. ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-... More
ADMA Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ADMA Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ADMA Biologics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.85 | |||
| Information Ratio | 0.0126 | |||
| Maximum Drawdown | 14.85 | |||
| Value At Risk | (4.27) | |||
| Potential Upside | 4.86 |
ADMA Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ADMA Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ADMA Biologics' standard deviation. In reality, there are many statistical measures that can use ADMA Biologics historical prices to predict the future ADMA Biologics' volatility.| Risk Adjusted Performance | 0.0426 | |||
| Jensen Alpha | 0.0041 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.013 | |||
| Treynor Ratio | 0.0856 |
ADMA Biologics February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0426 | |||
| Market Risk Adjusted Performance | 0.0956 | |||
| Mean Deviation | 2.22 | |||
| Semi Deviation | 2.74 | |||
| Downside Deviation | 2.85 | |||
| Coefficient Of Variation | 2266.17 | |||
| Standard Deviation | 2.94 | |||
| Variance | 8.65 | |||
| Information Ratio | 0.0126 | |||
| Jensen Alpha | 0.0041 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.013 | |||
| Treynor Ratio | 0.0856 | |||
| Maximum Drawdown | 14.85 | |||
| Value At Risk | (4.27) | |||
| Potential Upside | 4.86 | |||
| Downside Variance | 8.12 | |||
| Semi Variance | 7.51 | |||
| Expected Short fall | (2.42) | |||
| Skewness | 0.0281 | |||
| Kurtosis | 1.28 |
ADMA Biologics Backtested Returns
At this point, ADMA Biologics is not too volatile. ADMA Biologics secures Sharpe Ratio (or Efficiency) of 0.0365, which signifies that the company had a 0.0365 % return per unit of return volatility over the last 3 months. We have found twenty-eight technical indicators for ADMA Biologics, which you can use to evaluate the volatility of the firm. Please confirm ADMA Biologics' Semi Deviation of 2.74, risk adjusted performance of 0.0426, and Mean Deviation of 2.22 to double-check if the risk estimate we provide is consistent with the expected return of 0.0907%. ADMA Biologics has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.4, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ADMA Biologics will likely underperform. ADMA Biologics at this time shows a risk of 2.48%. Please confirm ADMA Biologics treynor ratio, downside variance, and the relationship between the total risk alpha and value at risk , to decide if ADMA Biologics will be following its price patterns.
Auto-correlation | -0.71 |
Almost perfect reverse predictability
ADMA Biologics has almost perfect reverse predictability. Overlapping area represents the amount of predictability between ADMA Biologics time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ADMA Biologics price movement. The serial correlation of -0.71 indicates that around 71.0% of current ADMA Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.71 | |
| Spearman Rank Test | -0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 0.63 |
ADMA Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ADMA Biologics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for ADMA Biologics across different markets.
About ADMA Biologics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ADMA Biologics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ADMA Biologics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ADMA Biologics price pattern first instead of the macroeconomic environment surrounding ADMA Biologics. By analyzing ADMA Biologics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ADMA Biologics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ADMA Biologics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.0781 | 0.0694 | Price To Sales Ratio | 10.78 | 11.31 |
ADMA Biologics February 11, 2026 Technical Indicators
Most technical analysis of ADMA help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ADMA from various momentum indicators to cycle indicators. When you analyze ADMA charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0426 | |||
| Market Risk Adjusted Performance | 0.0956 | |||
| Mean Deviation | 2.22 | |||
| Semi Deviation | 2.74 | |||
| Downside Deviation | 2.85 | |||
| Coefficient Of Variation | 2266.17 | |||
| Standard Deviation | 2.94 | |||
| Variance | 8.65 | |||
| Information Ratio | 0.0126 | |||
| Jensen Alpha | 0.0041 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.013 | |||
| Treynor Ratio | 0.0856 | |||
| Maximum Drawdown | 14.85 | |||
| Value At Risk | (4.27) | |||
| Potential Upside | 4.86 | |||
| Downside Variance | 8.12 | |||
| Semi Variance | 7.51 | |||
| Expected Short fall | (2.42) | |||
| Skewness | 0.0281 | |||
| Kurtosis | 1.28 |
ADMA Biologics February 11, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ADMA stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 38,184 | ||
| Daily Balance Of Power | (0.20) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 16.42 | ||
| Day Typical Price | 16.38 | ||
| Price Action Indicator | (0.19) |
Complementary Tools for ADMA Stock analysis
When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |